Hjelle KM - Search Results

1

Health-related quality of life in long-term survivors after renal cancer treatment.

Beisland C, Beisland E, Hjelle KM, Bostad L, Hjermstad MJ, Aarstad AK, Aarstad HJ. Beisland C, et al. Among authors: hjelle km. Scand J Urol. 2014 Feb;48(1):52-64. doi: 10.3109/21681805.2013.813963. Epub 2013 Jul 24. Scand J Urol. 2014. PMID: 23883326

2

[Transvesical prostatectomy].

Takle M, Hjelle K, Beisland C. Takle M, et al. Tidsskr Nor Laegeforen. 2007 Feb 15;127(4):435-7. Tidsskr Nor Laegeforen. 2007. PMID: 17304271 Free article. Norwegian.

3

Observation should be considered as an alternative in management of renal masses in older and comorbid patients.

Beisland C, Hjelle KM, Reisaeter LA, Bostad L. Beisland C, et al. Among authors: hjelle km. Eur Urol. 2009 Jun;55(6):1419-27. doi: 10.1016/j.eururo.2008.12.031. Epub 2009 Jan 7. Eur Urol. 2009. PMID: 19147267

4

Obesity is associated with an improved cancer-specific survival, but an increased rate of postoperative complications after surgery for renal cell carcinoma.

Rogde AJ, Gudbrandsdottir G, Hjelle KM, Sand KE, Bostad L, Beisland C. Rogde AJ, et al. Among authors: hjelle km. Scand J Urol Nephrol. 2012 Oct;46(5):348-57. doi: 10.3109/00365599.2012.678382. Epub 2012 Apr 25. Scand J Urol Nephrol. 2012. PMID: 22530756

5

Incidentally detected renal cell carcinomas are highly associated with comorbidity and mortality unrelated to renal cell carcinoma.

Sand KE, Hjelle KM, Rogde ÅJ, Gudbrandsđottir G, Bostad L, Beisland C. Sand KE, et al. Among authors: hjelle km. Scand J Urol. 2013 Dec;47(6):462-71. doi: 10.3109/21681805.2013.777364. Epub 2013 Mar 21. Scand J Urol. 2013. PMID: 23517346

6

Contemporary external validation of the Leibovich model for prediction of progression after radical surgery for clear cell renal cell carcinoma.

Beisland C, Gudbrandsdottir G, Reisæter LA, Bostad L, Wentzel-Larsen T, Hjelle KM. Beisland C, et al. Among authors: hjelle km. Scand J Urol. 2015 Jun;49(3):205-10. doi: 10.3109/21681805.2014.980844. Epub 2014 Nov 25. Scand J Urol. 2015. PMID: 25423093

7

Beisland E, Beisland C, Hjelle KM, Bakke A, Aarstad AK, Aarstad HJ. Beisland E, et al. Among authors: hjelle km. Scand J Urol. 2015;49(4):282-9. doi: 10.3109/21681805.2014.990051. Epub 2014 Dec 17. Scand J Urol. 2015. PMID: 25515950

8

Preoperative high levels of serum vascular endothelial growth factor are a prognostic marker for poor outcome after surgical treatment of renal cell carcinoma.

Guðbrandsdottir G, Hjelle KM, Frugård J, Bostad L, Aarstad HJ, Beisland C. Guðbrandsdottir G, et al. Among authors: hjelle km. Scand J Urol. 2015;49(5):388-94. doi: 10.3109/21681805.2015.1021833. Scand J Urol. 2015. PMID: 25773545

9

Transcriptome Sequencing (RNAseq) Enables Utilization of Formalin-Fixed, Paraffin-Embedded Biopsies with Clear Cell Renal Cell Carcinoma for Exploration of Disease Biology and Biomarker Development.

Eikrem O, Beisland C, Hjelle K, Flatberg A, Scherer A, Landolt L, Skogstrand T, Leh S, Beisvag V, Marti HP. Eikrem O, et al. PLoS One. 2016 Feb 22;11(2):e0149743. doi: 10.1371/journal.pone.0149743. eCollection 2016. PLoS One. 2016. PMID: 26901863 Free PMC article.

10

A prospective risk-stratified follow-up programme for radically treated renal cell carcinoma patients: evaluation after eight years of clinical use.

Beisland C, Guðbrandsdottir G, Reisæter LA, Bostad L, Hjelle KM. Beisland C, et al. Among authors: hjelle km. World J Urol. 2016 Aug;34(8):1087-99. doi: 10.1007/s00345-016-1796-4. Epub 2016 Feb 27. World J Urol. 2016. PMID: 26922650

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

44 results

Search Page